CRISPR is a gene-editing company that develops and commercializes gene-based medicines for the treatment of serious diseases.
Business Model:
Revenue: $2M
Employees: 201-500
Address: Baarerstrasse 14
City: Zug
State: zug
Zip: CH-6300
Country: CH
CRISPR is a gene-editing company that develops and commercializes gene-based medicines for the treatment of serious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/19/2016
IPO Valuation:
$590M
Ticker Symbol:
CRSP
IPO Price:
$15/share
Amount Raised:
$56M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|